Found 102 matching trials
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Pancreatic Adenocarcinoma Signature Stratification for Treatment PHASE2 This is a randomized multicentre phase II trial with a large translational ...
Show More Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Learn More & Join Trial
A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer PHASE2 Pancreatic cancer is a serious condition and is one of the leading cause of...
Show More Location
Jewish General Hospital
Learn More & Join Trial
The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma N/A Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with a...
Show More Location
Zhejiang Province Cancer Hospital
Learn More & Join Trial
Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC EARLY_PHASE1 Lenvatinib Plus Hepatic Arterial Infusion of Modified FOLFOX Regime vs Lenv...
Show More Location
The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)
Learn More & Join Trial
Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma PHASE1 The prognosis of pancreatic cancer is extremely poor. Current guidelines re...
Show More Location
The second affiliated hospital of Zhejiang University
Learn More & Join Trial
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. N/A Ampullary adenocarcinoma (AAC) is a rare gastrointestinal cancer with varyi...
Show More Location
Fondazione Poliambulanza
Learn More & Join Trial
Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas PHASE2 This prospective cohort, phase II, trial is studying induction chemotherapy...
Show More Location
Assiut University Hospitals
Learn More & Join Trial
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer PHASE2 The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Show More Location
Shanghai Cancer Center
Learn More & Join Trial
FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer PHASE2 The purpose of this study is to find out if an experimental drug will preve...
Show More Status
Active Not Recruiting
Location
University of Colorado Cancer Center
Learn More & Join Trial